List of 2019 Speakers


2019 Conference Speakers


David Allison, Partner, 5AM Ventures
Paul Biondi
, SVP, Strategy and Business Development, Bristol-Myers Squibb
Katherine BowdishVice President Global R&D and Head of Sunrise Ventures, Sanofi U.S.
Dan Bradbury, Chairman and CEO, Equillium
Jason Dinges, Investment Advisory, Morningside Ventures
Mike Dudley, President and CEO, Qpex Biopharma
Jon Edwards
Partner, Medicxi
Luke Evnin, Managing Director, MPM Capital
Don Frail, Senior Vice President, Research, External Science & Innovation, and Non-Clinical and Translational Sciences, Allergan
Carl Goldfisher, Managing Director, Bay City Capital
Kevin Gorman, CEO, Neurocrine Biosciences 
Henry Gosebruch,
EVP, Chief Strategy Officer, AbbVie
Chris Haskell
Vice President and Head, West Coast Innovation Center, Bayer
Natasha Hernday, Senior VP Corporate Development, Seattle Genetics
Rich Heyman, Chairman of the BOD, Metacrine Inc.
David Kabakoff, Executive Partner, Sofinnova Ventures
Chau KhuongPrivate Equity Partner, Orbimed
Damien McDevitt, Chief Business Officer, Ionis Pharmaceuticals
Diego Miralles, CEO, Vividion Therapeutics
Ron NewboldSenior Vice President and Head of US Business Development & Alliance Management, Otsuka America Pharmaceuticals
Carole NuechterleinHead, Roche Venture Fund
Heather Preston, Managing Partner, Pivotal bioVenture Partners
John Reed, M.D., Ph.D., Executive Vice President, Global Head of Research & Development, Sanofi 
Camille SamuelsPartner, Venrock
Ioannis Sapountzis, US Head, Business Development & Licensing Specialty Pharma, Boehringer Ingelheim Pharmaceuticals, Inc.
Avi Spier, Director, NIBR BD&L, Search and Evaluation, Novartis
Carolyn Stout,
Principal, EcoR1 Capital, LLC
Alex Szidon, Head, West Coast Innovation Hub, Merck
D.A. Wallach, Co-Founder, Inevitable Ventures
Jeffrey Warmke
Senior Vice President, External Scientific Affairs, Daiichi Sankyo